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Abstract
Background: Acute respiratory illnesses and influenza-like illnesses (ILI) are a significant source of morbidity and mortality
worldwide. Despite the public health importance, little is known about the etiology of these acute respiratory illnesses in
many regions of South America. In 2006, the Peruvian Ministry of Health (MoH) and the US Naval Medical Research Center
Detachment (NMRCD) initiated a collaboration to characterize the viral agents associated with ILI and to describe the clinical
and epidemiological presentation of the affected population.
Methodology/Principal Findings: Patients with ILI (fever $38uC and cough or sore throat) were evaluated in clinics and
hospitals in 13 Peruvian cities representative of the four main regions of the country. Nasal and oropharyngeal swabs, as
well as epidemiological and demographic data, were collected from each patient. During the two years of this study (June
2006 through May 2008), a total of 6,835 patients, with a median age of 13 years, were recruited from 31 clinics and
hospitals; 6,308 were enrolled by regular passive surveillance and 527 were enrolled as part of outbreak investigations. At
least one respiratory virus was isolated from the specimens of 2,688 (42.6%) patients, with etiologies varying by age and
geographical region. Overall the most common viral agents isolated were influenza A virus (25.1%), influenza B virus (9.7%),
parainfluenza viruses 1, 2, and 3, (HPIV-1,-2,-3; 3.2%), herpes simplex virus (HSV; 2.6%), and adenoviruses (1.8%). Genetic
analyses of influenza virus isolates demonstrated that three lineages of influenza A H1N1, one lineage of influenza A H3N2,
and two lineages of influenza B were circulating in Peru during the course of this study.
Conclusions: To our knowledge this is the most comprehensive study to date of the etiologic agents associated with ILI in
Peru. These results demonstrate that a wide range of respiratory pathogens are circulating in Peru and this fact needs to be
considered by clinicians when treating patients reporting with ILI. Furthermore, these data have implications for influenza
vaccine design and implementation in South America.
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Introduction
Influenza-like illnesses (ILI) are a significant source of morbidity
and mortality worldwide. In many parts of the world, particularly
in temperate regions of the Northern Hemisphere such as the
United States and Europe, the etiologic agents associated with ILI
have been well characterized. In much of Latin America, however,
the epidemiology and etiology of ILI are poorly understood. ILI
can be attributed to a wide range of respiratory viruses, including
influenza viruses, adenoviruses, respiratory syncytial virus (RSV),
enteroviruses, human metapneumovirus (HMPV), and parainflu-
enza viruses. Adenovirus, RSV, and parainfluenza viruses can
cause severe disease particularly in children, accounting for a
considerable proportion of childhood morbidity and mortality
[1,2]. Enteroviruses and HSV have been isolated from patients
with acute respiratory infections and these viruses may also cause
infections such as pharyngitis [3,4]. Patients infected by these
diverse viral pathogens present with widely overlapping sympto-
mology, which render clinical diagnosis unreliable and severely
limits etio-epidemiological studies.
The predominant pathogens of ILI are typically the influenza
viruses which cause annual recurrent epidemics affecting an
estimated 5–15% of the population presenting with upper
respiratory tract infections worldwide. The World Health
Organization (WHO) estimates that globally there are 3–5 million
severe cases and 250,000–500,000 deaths globally [5] due to
influenza every year, with most deaths occurring among elderly
populations. Influenza viruses are genetically labile and are thus
able to adapt and elude the host immune response, leading to
regular seasonal influenza circulation and occasional pandemic
events [5–7]. Vaccination is considered the best transmission
prevention method; however, the vaccine must be updated
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an international influenza surveillance network, the WHO
identifies the viral strains that are to be included in the vaccine
for the following transmission period in both the Northern and
Southern Hemispheres [9–11]. Selecting the appropriate antigens
for the annual vaccine requires surveillance systems to be in place
worldwide to monitor circulating variants.
Since 1998, the Ministry of Health (MoH) of Peru has conducted
virological surveillance of influenza and other respiratory viruses
[12,13]. In 2006, to strengthen the National Peruvian surveillance
program, the MoH Sub-committee of Influenza Surveillance
invited the US Naval Medical Research Center Detachment
(NMRCD) in Lima, Peru to assist in increasing surveillance
coverage by establishing new sentinel sites. Since then, NMRCD
has augmented the existing program with support for obtaining and
processing samples from new sentinel sites as well as providing data
to the Epidemiology Directorate and the National Institute of
Health of Peru. The objectives of the present study were to describe
the clinical and epidemiological presentation of ILI in the study
population, identify the etiologic agents associated with ILI, and
molecularly characterize the influenza viruses isolated from patient
specimens. Herein we present the data on the viral agents causing
ILI in Peru from June 2006 through May 2008, based on results
from NMRCD-MoH study sites in 13 cities across the country.
Materials and Methods
Case Definition
At each site, trained medical personnel were responsible for
properly identifying and classifying patients with ILI. The case
definition was ‘‘any person with a sudden onset of fever ($38uC)
and cough or sore throat fewer than 5 days in duration,
accompanied or not by general symptoms such as myalgias,
prostration, headache or malaise’’ [14].
Study Population
The study population included every patient with ILI,
regardless of age, who sought attention in participating health
centers between June 2006 and May 2008 and agreed to
participate in the study.
Peru is divided by the Andes Mountains into naturally distinct
regions (highlands, coastal desert and jungle) all extending the
entire length of the country. The capital city of Lima serves as a
reference point dividing the northern and southern regions.
Participants (outpatient or inpatient) were recruited in 31 hospitals
or health centers in 13 Peruvian cities located in 10 provinces,
which were intended to represent four distinct geographic regions
of the country. The sites included in this study were from 1) the
southern highlands, including Arequipa, Cusco, Puno and Juliaca,
all located over 2,500 meters above sea level; 2) the northern
coastal desert, including Tumbes, Piura and Sullana, all with
limited rainfall (,20 cm/year); 3) the jungle region, including
Puerto Maldonado, Pucallpa, Iquitos and Yurimaguas, where
rainfall exceeds 200 cm yearly; and 4) the central region of the
country, including La Merced (Chanchamayo) and Lima
(Figure 1). In each city, at least two accessible health centers were
included from urban areas. Hospitalization was noted if the
patient spent at least one night in the hospital or health center.
Study participants from Sullana, Arequipa, Puno, Pucallpa and
Iquitos also included military personnel who presented at local
military health centers. Military populations were included from
ILI outbreaks occurring in any military base (army or navy) within
Peru. While participants recruited during outbreak investigations
were excluded from epidemiological analyses of each geographical
region, some outbreak-related samples were included in the
molecular characterization to provide broader coverage and
description of circulating influenza virus variants.
Data Collection and Management
Data on gender, age, lost work or school days, previous
treatment, medical attention before enrollment, influenza vaccina-
tion status and travel in the last 7 days were collected utilizing a case
report form (CRF) from all participants who met the case definition.
Temporal distribution of the results were recorded by month
and epidemiological week (EW) during the study period, taking
into account the number of ILI cases identified and the number of
confirmed cases of influenza A and B in each geographical region.
Weekly reports of enrolled ILI participants and monthly
laboratory results were sent to the MoH. Regular personnel
training in protocol procedures and semi-annual site visits were
conducted as part of the strategy to improve sampling, storage and
shipping procedures.
Local coordinators notified NMRCD when an outbreak was
suspected, and additional supplies were shipped to the site. When an
increased number of cases were detected in any health center,
PeruvianofficerswerenotifiedandtheRegionalMoHEpidemiology
Directorate determined if an outbreak investigation was necessary.
Laboratory Aanalysis
Sample collection. Two types of samples were obtained
from the cases for diagnostic testing: a nasal swab for the Rapid
Influenza Test (RIT; QUICKVUE Influenza test, Quidel, San
Diego, CA) and an oropharyngeal swab for viral isolation. The
RIT was processed on site, and the results were provided to the
patient. Oropharyngeal swabs were placed in transport media and
stored at 270uC until they were delivered on dry ice to NMRCD
for laboratory analysis.
Virus isolation and identification. Patient specimens were
inoculated into four cell lines for virus isolation: Madin-Darby
canine kidney (MDCK), African green monkey kidney (Vero76 and
VeroE6) and Rhesus monkey kidney (LLCMK2) cells. Upon the
appearance of a cytopathic effect (CPE) or after ten (or thirteen in
the case of Vero cells) days of culture, the cells were spotted onto
microscope slides. Cell suspensions were dried and fixed in chilled
acetone for 15 minutes. Immunofluorescence assay (IFA) was
performed to identify the virus isolates using a direct fluorescense
assay (DFA). The Respiratory Virus Screening and Identification
Kit (D3 DFA Respiratory Virus Diagnostic Hybrids, Athens, OH)
was utilized for the identification of adenoviruses, influenza A virus,
influenzaBvirus,parainfluenzaviruses(types1,2,and 3),andRSV.
TheD3DFAHSVidentificationkit and theD3IFA EnterovirusID
kit (Diagnostic hybrids) were utilized for the identification of HSV
and enteroviruses respectively. All assays were performed following
the manufacturer’s established protocols.
Cases with positive RIT results, but without confirmatory virus
isolation results were further tested for influenza A and B viruses
by using a one step reverse transcriptase-polymerase chain
reaction (RT-PCR) with the influenza primers described below.
The viral etiology of cases was based on the isolation of virus (CPE
and/or IFA/DFA positive) and/or a positive result by both RIT
and RT-PCR
RNA extraction and RT-PCR. For the genetic analyses of
influenza viruses, viral RNA extraction was performed from the
supernatant of infected MDCK cells using a QIAamp Viral RNA
kit(QIAGEN, Valencia, CA)followingthe manufacturer’s protocol.
The one-step RT-PCR was performed with primers that amplify
the hemagglutinin (HA) gene of influenza A and influenza B viruses
using the SuperScript III One-Step RT-PCR System kit
ILI Surveillance in Peru
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the amplification of H1 influenza A viruses: H1F-6 (59-
AAGCAGGGGAAAATAAAA-39) and H1R-1193 (59-
GTAATCCCGTTAATGGCA-39); for H3 influenza A viruses:
H3F-7 (59-ACTATCATTGCTTTGAGC-39) and H3R-1184 (59-
ATGGCTGCTTGAGTGCTT-39); for influenza B viruses:
BHAF-36 (59-GAAGGCAATAATTGTACT-39) and BHAR-
1140 (59-ACCAGCAATAGCTCCGAA-39). Five mlo ft h e
extracted RNA was added to 20 ml of master mix containing the
enzyme mixture (SuperScript III RT/Platinum Taq), 2X reaction
mixture(containing0.4 mMofeachdNTPand3.2 mMofMgSO4)
and 20 mM of each primer. Cycling conditions included a reverse
transcription step at 50uC for 30 minutes and a denaturation step at
94uC for 2 min. Cycling conditions of the PCR were 40 cycles of
94uC for 15 seconds, 52uC for 30 seconds, and 68uC for 75 seconds,
followed by a final incubation step at 68uC for 5 min.
The RT-PCR products were purified using Centri-Sep
Columns (Princeton Separation, Englishtown, NJ) and sequenced
using the BigDye Terminator v. 3.1 Cycle Sequencing Kit
(Applied Biosystems, Foster City, CA) following manufacturers’
standard procedures. Sequences were analyzed and edited using
the Sequencer 4.8 software (Applied Biosystems Foster City, CA)
Sequencing and phylogenetic analysis. The nucleotide
sequences were aligned using the Clustal program in the Mac
Vectorsoftware package (Mac Vector Inc., Cary, NC), and
phylogenetic analyses were performed using the neighbor joining
and maximum likelihood algorithms implemented in the
phylogenetic analysis using parsimony (PAUP) software [15,16].
For the neighbor joining analyses the HKY85 distance was used
and bootstrap values were calculated based on 1000 replicates to
place confidence values on grouping within trees.
Ethical Management
This surveillance protocol (NMRCD.2002.0019) was approved
as less than minimal risk research by the NMRCD Institutional
Review Board (IRB) and the Peruvian MoH, and written consent
forms were not required. Stamped, approved information sheets
were used in place of written consent forms. Additionally, the
study database was shared with the Epidemiology Directorate at
the Peruvian MoH
Statistical Analysis
The clinical-epidemiological forms were entered into a database
created in Microsoft (MS) Office Access 2003, and data were
analyzed using dynamic tables in MS Excel 2003.
The Chi square and Fisher exact tests were used to compare
means and associations using SPSS software version 10.0 (SPSS
Inc., Chicago, IL).
Results
General Findings
A total of 6,835 participants from general hospitals and health
centers located in 13 different cities were enrolled in this study, of
Figure 1. Viral etiology of ILI in Peru distributed by age and geographic region, June 2006–May 2008.
doi:10.1371/journal.pone.0006118.g001
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6,308 were recruited during routine surveillance activities, and 527
were recruited during outbreak investigations. The patients ranged
in age from #1 to 94 years with a median age of 13 years and a
mean age of 16 years (SD 16.4 yrs); 56.4% of participants were
under 15 years of age, and 8.1% were older than 45 years. From
4,552 ILI cases between 5 and 65 years of age, 1,213 (26.6%)
reported lost school or working days because of the illness; 85% of
whom lost 2 days or fewer (mean 1.7 days; SD 1.2 days). A total of
116 (1.7%) participants reported a history of influenza vaccination
for that season (Table 1).
Laboratory Findings
Of the samples collected during routine surveillance, 2,688
(42.6%) were positive for respiratory viruses by isolation; of those
1,583 (25.1%) were positive for influenza A virus, 609 (9.7%) for
influenza B virus, 115 (1.8%) for an adenovirus and 202 (3.2%) for
parainfluenza 1, 2 or 3 viruses (Table 2). Viral etiology of ILI cases
by age and region is shown in Figure 1.
Among sites (Table 2), the percentage of samples positive for
one or more viral pathogens ranged between 27.8% (Pucallpa) and
50.8% (Piura). The highest prevalence of influenza B virusamong
ILI patients was in La Merced, Iquitos and Piura, all exceeding
Table 1. Characteristics of the study population.
No. (%)
Number of samples (total patients enrolled) 6835(100)
Respiratory virus positive (regular passive surveillance) 2688(42.6)
Influenza virus positive (influenza A and B) 2192(34.8)
Respiratory virus positive (total patients enrolled) 2840(41.6)
Sex Female 3049(44.6)
Male 3786(55.4)
Age (N=6385) Mean, 6SD 16, 616.4 yrs
Median, [range] 13, [0–94]
0–4 yrs 2267(35.5)
5–14 yrs 1337(20.9)
15–29 yrs 1961(30.7)
30–44 yrs 733(11.5)
45–59 yrs 367(5.7)
.60 yrs 154(2.4)
Travel (last 7 days) 888(13)
Vaccination history 116(1.7)
Hospitalized 209(3.1)
Lost work/school days (n=1213 between 5–65 years) Mean, 6Std 1.7, 61.2 days
Median, [range] 1, [0.13–12]
,1 days 64(5.3)
1 day 672(55.4)
2 days 283(23.3)
3 days 114(9.4)
.4 days 80(6.6)
Medical attention before enrollment 2191(32.1)
Previous treatment Antibiotics 1021(14.9)
Others 2869(42)
Unknown 160(2.3)
No treatment 2508(36.7)
Missing 277(4.1)
Military population 968(14.2)
Civilian population 5867(85.4)
Outbreak population 527(7.7)
Positive rapid test Influenza A 1212(17.7)
Influenza B 516(7.5)
Undifferentiated 175(2.6)
Negative rapid test 4592(67.2)
No test 340(5)
doi:10.1371/journal.pone.0006118.t001
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the other locations (p,0.001). Relative to the other study sites, a
significantly higher prevalence of adenovirus infection was
observed among study participants in the northern coastal sites
of Tumbes and Piura (p,0.001) and a significantly lower
prevalence of adenovirus infection was observed at study sites in
Cusco (p,0.001). HSV was isolated from 164 (2.6%) ILI patients
and the highest percentage of HSV isolation was observed in the
coastal cities of Lima, Tumbes, and Piura (Table 2). Viral co-
infection was detected in 34 (20.7%) HSV-positive cases, including
20 (12%) who had HSV and influenza A virus co-infection
(Table 2), which was the most frequent co-infection found in the
study. We also identified 3 (0.04%) patients with co-infection by
HSV and parainfluenza viruses. Of patients with HSV infection,
106 (60%) were under 15 years of age, 66 (38%) of whom were
between 0–4 years of age. In total, RSV was isolated from 40
(0.6%) cases; however it was not isolated from patients reporting to
clinics in Arequipa, Cusco or La Merced.
The prevalences of influenza A and B viruses were significantly
different between the different age groups (p,0.001), with a higher
prevalence among patients older than 5 years. Parainfluenza
viruses, enteroviruses, RSV, HSV and adenoviruses were more
common among patients younger than 5 than in the older age
groups (Figure 1).
To determine the efficacy of in situ influenza testing, RIT results
were compared with laboratory isolation results. Sensitivity of RIT
was 73% (1,636/2,250) and specificity was 94% (3,978/4,245).
The positive predictive value of the RIT was 85% (1,636/1,903).
Clinical Data
Fever, cough, malaise and rhinorrhea were the major symptoms
(each observed in over 80% of the patients) for all age groups and
geographical regions, although sore throat (71%) and headache
(63%) were also frequently recorded. Rhonchus (17%) and
wheezing (7%) were more frequent in patients younger than 5
years in contrast to what was seen in older patients, especially
those who were positive for an influenza virus. A total of 209
(3.1%) patients with ILI were hospitalized (Table 1). There was no
significant association between any pathogen and higher hospital-
ization rates (p.0.05).
Sore throat and vesicular lesions on the lips, mouth or throat
were reported by 120 (68%) and 11 (6.2%) of the HSV-positive
patients, respectively.
A total of 1,021 (14.9%) ILI patients reported receiving
antibiotics before enrollment into the study. Of these patients,
248 (24%) were found to be infected with influenza A virus, 121
(11.9%) with influenza B virus, 18 (1.7%) with adenoviruses and
30 (2.9%) with parainfluenza viruses. RIT was positive for 32.7%
of participants who had received antibiotics at some point prior to
enrollment.
Outbreaks and Military Population
A total of 968 military personnel were enrolled, making up 14%
of the total study population (Table 1). Of those, 466 (48%) were
enrolled during regular surveillance activities maintained at
regional military hospitals at Sullana, Arequipa, Pucallpa, and
Iquitos. The remaining 502 (52%) were enrolled during outbreaks
in military populations at Tumbes, Piura, La Merced and Lima,
making up the majority (95%) of the 527 total participants
recruited during outbreak investigations (Table 1). One of the
main outbreaks in 2007 included 124 ILI cases from two army
bases in Tumbes on the northern coast[17]. A total of 66 influenza
cases were confirmed by cell culture, including 54 cases of
influenza B virus infection and 12 cases of influenza A virus
infection. Isolates were genetically similar to the influenza B virus
strain B/Texas/4/2006 (Victoria lineage) and the influenza H3N2
A virus strain A/Texas/91/2007 (A/Brisbane/10/07-lineage). In
2007 as well, a total of 82 ILI cases were enrolled during another
outbreak at the La Merced army base in central Peru; 32 were
influenza B virus-positive by isolation and 16 were influenza A
virus-positive (Table 2).
Temporal and Geographical Distribution of Influenza A
and B Virus Infections
The temporal distribution of total ILI and confirmed influenza
cases identified at study sites nationwide between the 22
nd
Epidemiological week (EW) of 2006 and the 20
th EW of 2008 is
shown in Figure 2. During the second half of 2006, influenza A
virus was predominant, while very few cases of influenza B virus
were detected. All influenza B virus infections during 2006 were
detected in study sites along the northern coast (Figures 3A, 3B,
3C,). Influenza B virus continued to circulate at low levels between
the 2
nd and 10
th EW of 2007 before becoming the predominant
influenza virus species during the 10
th and 28
th EW (Figure 2). A
simultaneous increase in the healthcare demand for ILI cases in
Tumbes, Piura, Arequipa, Iquitos and La Merced was observed
during this period.
In the southern highlands, peaks of influenza A and B virus
infections were observed between the19th and the 28th EW in
2007 coinciding with the winter season in that region. With the
exception of this time period the number of influenza A and B
cases were relatively low in the southern highlands during 2007.
In the northern coast region (Tumbes and Piura), influenza
virus circulation was detected throughout the year during 2007;
influenza B viruses were identified mainly between the 14
th and
the 26
th EW. This detection of influenza B viruses corresponds to
an outbreak identified in two army bases in Tumbes (EW 16
through 18). In the Amazon jungle region (Iquitos, Pucallpa
Yurimaguas and Puerto Maldonado), very few cases of influenza A
virus infection were detected during 2007, although an increase of
influenza B cases was detected between the 5
th and the 16
th EW.
Over the period of 2008 reported here (through EW 22),
influenza A viruses predominated throughout the country,
approaching three times the number of influenza B cases
(Figure 2). In study sites in the southern highlands region very
few cases of influenza A and or B were detected during the first
months of 2008 (1
st–22
nd EW). Comparatively, in the northern
coast region, influenza A cases were more common than influenza
B cases, although an increase number of influenza B cases were
observed between the 6
th and 16
th EW (Figures 3A and 3C). In the
jungle region influenza B cases were also identified almost weekly
during the 1
st–22
nd EW period (Figure 3B).
Phylogenetic Analysis of the Influenza isolates
H1N1 influenza A viruses. Genetic analyses based on the
HA gene of 102 H1N1 influenza A isolates from Peru revealed
three distinct genotypes: 1) A/Solomon Islands/03/06-like, 2) A/
Brisbane/59/07-like and, 3) A/New Caledonia/20/99-like
(Figure 4).
Among the 2006 isolates from the northern coast (in red),
central (in blue) and southern highlands (in brown) regions, two
distinct genotypes were observed: A/Solomon Island/03/06-like
and the A/New Caledonia/20/99-like. The latter also includes the
recommended 2006/2007 vaccine strain for the Northern and
Southern Hemispheres (A/New Caledonia/20/99). All isolates
from the jungle region during 2006 grouped within the A/
Solomon Islands/03/06-like genotype.
ILI Surveillance in Peru
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ued to circulate in Peru. This genotype does not include the
recommended 2007 vaccine strain for the Southern Hemisphere
(A/New Caledonia/20/99).
The circulation of the A/Brisbane/59/07-like genotype was
detected among the 2008 isolates from the northern coast and
southern highland regions. Furthermore, this genotype does not
include the recommended 2008 vaccine strain A/Solomon
Islands/03/06.
H3N2 influenza A viruses. Genetic analyses based on the
HA gene of 134 H3N2 influenza A viral isolates circulating in Peru
from 2006 through 2008 revealed that the 2007–2008 influenza
strains grouped within the A/Brisbane/10/07-like genotype,
which includes the 2008 vaccine strain from the Southern
Hemisphere (A/Brisbane/10/07). The influenza A H3N2 virus
strains from all geographical regions of Peru were grouped into
this single genotype (Figure 5). The 2006 influenza A H3N2 virus
isolates differ genetically from the recommended 2006 vaccine
strain A/California/07/04.
Influenza B viruses. Phylogenetic analyses based on the HA
sequence of 169 influenza B virus isolates revealed the presence of
two genotypes in Peru: B/Malaysia/2506/07-like and B/Florida/
4/06-like. These genotypes co-circulated in Peru in 2006 and
2007; however, the most recent influenza B virus isolates from
2008 belong to the B/Florida/04/06 genotype, which also
includes the vaccine strain for the Southern Hemisphere (Figure 6).
Discussion
Prior to this study, there has been little documentation on the
circulating respiratory viruses in most regions of South America.
To date, the data presented here represent the most thorough
description of ILI-causing viruses throughout Peru. During the two
years of surveillance reported in this study, upper respiratory
viruses were isolated from greater than 40% of samples collected
from nearly 7,000 patients with ILI. As expected, influenza A
(23.8% of the total cases) was the predominant diagnosis. During
the period of the study, however, we also observed the
introduction and emergence of influenza B viruses in these study
sites. In addition, parainfluenza viruses, enteroviruses, adenovi-
ruses, and HSV were isolated from patient specimens, which
collectively contributed to 8.8% of all ILI cases in our study. The
prevalences of influenza A and B viruses were significantly higher
in ILI patients older than 5 years of age (p,0.001), while other
viruses such as parainfluenza, adenovirus, enterovirus, HSV and
RSV were more prevalent among participants younger than 5
years. These results are consistent with studies in other regions of
South America [18,19]. Taken together, these data demonstrate
that a wide range of viruses need to be considered during the
diagnosis of human respiratory illness.
HSV is a viral agent not usually considered in patients with upper
respiratory complaints. In our study HSV was isolated from 176
(2.6%) of ILI patients. In addition to the respiratory symptoms, we
found that 11 (6.2%) HSV-positive participants also had vesicular
lesions on the lips, mouth or throat. Mc Millan [3], in a 16-month
study of U.S. college students, found that 5.7% of patients with sore
throats had HSV infection and, of those 34% had vesicular lesions
and 71% had pharyngeal erithema. In our study, in the majority of
cases where HSV was isolated,no other viralinfection wasdetected.
However, as HSV is a latent virus that may be reactivated during
infections with other pathogens, we cannot conclude that HSV is
the causative agent for the infections reported in this study. In
addition, it should be noted that nearly 60% of total ILI cases were
undiagnosed; suggesting that in HSV-positive cases where no other
infection was detected as-of-yet unidentified pathogens may be
responsible for the ILI symptoms. A control group without ILI
symptoms will be needed to draw more definite conclusions on the
role of HSV as a causative agent of ILI symptoms. Nevertheless
these data suggest that in the future, HSV should be considered in
diagnostic evaluations as a potential cause of ILI.
Distribution of the ILI-causing viruses varied by study site and
by region. For example, adenoviruses were more common along
the northern coast, in Tumbes and Piura (p,0.001) and much less
common in Cusco (p,0.001). The geographic distribution of
influenza viruses varied considerably as well. For influenza A
viruses, the H3N2 strains predominated in the southern regions of
Figure 2. Temporal distribution by month and epidemiological week (EW) of influenza A and B confirmed cases, Peru 2006–2008.
doi:10.1371/journal.pone.0006118.g002
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PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6118Figure 3. Temporal distribution of total ILI and influenza A and B cases by month and epidemiological week (EW) and by region.
A)northern coast region. B) jungle regionC) south highlands region.
doi:10.1371/journal.pone.0006118.g003
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PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6118the country (Arequipa, Cusco, Puno, and Puerto Maldonado,
specifically), while influenza B viruses were more common in the
northern and central regions (Tumbes, Piura, Iquitos, and La
Merced). However, it should be noted that almost all detected
influenza strains and lineages were found in all study sites,
suggesting that newly introduced viral strains will spread to all
Figure 4. Phylogenetic tree based on the partial hemagglutinin (HA) sequence of influenza A H1N1 viruses. Numbers indicate
bootstrap values. The legend indicates the geographical origin of the strains: southern highlands (brown), coastal (red), jungle (green) and central
(blue) regions. Arrows indicate the recommended vaccine strain for the Southern Hemisphere for each year of the study period.
doi:10.1371/journal.pone.0006118.g004
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time for an adequate description of the seasonal patterns of
influenza transmission; we did observe trends in different regions.
In the southern highlands, sunny days and dry weather are
characteristic during the autumn and spring. It was during the
winter season when temperatures fall to 3 to 25uC that an
increased number of influenza A and B cases were detected in
both 2006 and 2007. This is consistent with unpublished data from
the MoH. Comparatively, we found another trend in the northern
coast and jungle regions where high humidity and hot weather are
characteristic of the entire year; in these regions influenza virus
transmission was detected throughout the year.
Figure 5. Phylogenetic tree based on the partial hemagglutinin (HA) sequence of influenza A H3N2 viruses. Numbers indicate
bootstrap values. The legend indicates the geographical origin of the strains: southern highlands (brown), coastal (red), jungle (green) and central
(blue) regions. Arrows indicate the recommended vaccine strain for the Southern Hemisphere for each year of the study period.
doi:10.1371/journal.pone.0006118.g005
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thepotentialforsampling bias.Aswehavelimited ourstudiestotwo
health centers in mostcities, our results may not be representative of
the entire population. Additionally, we are unable to calculate
incidence rates based on our study due to this bias and the lack of
reliable population data. To address this shortcoming, we are
establishing community-based active surveillance programs in
several of these sites to better quantify the impact of ILIs on the
population at large. One advantage of the present surveillance is the
ability to identify increases in the number of patients seeking
medical attention due to ILI symptoms and the diagnosis of the
viruses related to such increases, while requiring fewer resources
than would be necessary in a population-based study. Furthermore,
we found similar influenza viruses present throughout the country,
suggesting that a sentinel surveillance program is sufficient for
detecting and describing currently circulating influenza lineages.
Figure 6. Phylogenetic tree based on the partial hemagglutinin (HA) sequence of influenza B viruses. Numbers indicate bootstrap
values. The legend indicates the geographical origin of the strains: southern highland (brown), coastal (red), jungle (green) and central (blue) regions.
Arrows indicate the recommended vaccine strain for the Southern Hemisphere for each year of the study period.
doi:10.1371/journal.pone.0006118.g006
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influenza strains to help evaluate current vaccine components and
inform the composition of future vaccine cocktails. The MoH is
planning to start massive vaccination campaigns for at-risk
populations in Peru. For influenza A H1N1 viruses, three
genotypes were observed: A/Solomon Island/03/06-like, A/
Brisbane/59/07-like and A/New Caledonia/20/99-like. These
genotypes include isolates that circulated in Peru in 2006 but have
not been detected since. It is unclear whether this genotype has
become extinct or whether it continues to circulate at low levels in
the Peruvian population. Importantly, our genetic analyses
revealed that the recommended 2007 vaccine strain A/New
Caledonia/20/99 does not group with the H1N1 strains that
circulated in Peru in 2007, suggesting that the vaccine was not
protective against the 2007 circulating strains. Similarly, the 2008
recommended vaccine strain A/Solomon Islands/03/06 does not
group with the 2008 isolates from Peru.
In contrast to the genetic diversity observed with the influenza A
H1N1viruses, influenza A H3N2 isolates circulating in Peru in
2007 and 2008 grouped into a single clade irrespective of
geographical regions. These isolates were found to be genetically
similar to the A/Brisbane/10/07 vaccine strain, supporting the
selection of the strain as part of the 2008 vaccine for the Southern
Hemisphere. Importantly, the 2006 isolates from Peru were found
to be genetically distinct to the recommended vaccine strain A/
California/07/04. Overall, these data highlight the necessity for
continuous influenza surveillance in South America and the need
for sharing this information with WHO reference laboratories for
proper evaluation and better selection of future Southern
Hemisphere vaccines.
Genetic analyses of influenza B virus isolates revealed the
presence of two genotypes in Peru: B/Malaysia/2506/07-like and
B/Florida/4/06-like. Both genotypes co-circulated in Peru in
2006 and 2007; however, the most recent influenza B isolates from
2008 belong to the B/Florida/4/06 genotype, which also includes
the vaccine strain for the Southern Hemisphere (B/Florida/04/
06). Future studies should identify whether this genotype will be
the dominant genotype in the current influenza season or whether
both lineages will continue to co-circulate. Such data will be
important for defining the components of the yearly vaccine.
In Peru like in other South American countries [20], the
unnecessary use of antibiotics is a generalized problem. In this
study, 15% of the participants had received antibiotics prior to
enrollment, and thus prior to a definitive diagnosis. A large
percentage of these participants were found to have a viral agent
associated with their illness. These data demonstrate that
unnecessary antibiotic use is common for treatment of a patient
with influenza-like illness, even without a definitive diagnosis of the
etiologic agent [21]. For many of these participants the purchase of
antibiotics combinated with paying for the clinic visit can be a
major economic imposition thus, it is important to have a better
understanding of the pathogens most commonly associated with
ILI in the region for both diagnostic and economic purposes. In
this study, RIT results were available at the time of enrollment,
which helped decrease the unnecessary continual use of antibiotics
and thus provided an additional economic benefit for the patients.
Unfortunately our study design does not permit us to determine
definitively what percentage of participants received antibiotics
following a positive RIT result, as follow up interviews were not
conducted. We also did not ask participants about use of antiviral
drugs since viral inhibitors are not a commonly used treatment for
influenza infection in Peru, mostly due to their high cost and low
availability. It is interesting to note, nonetheless, that we found that
a high percentage of circulating influenza A H3N2viruses are
resistant to antiviral drugs such as Amantadine based on
secondary analysis of these isolates [22].
These data provide initial background levels of transmission of
influenza viruses and other ILI-related viruses in several regions of
Peru. Such data are important for identifying strategic locations to
establish cohorts in the context of intervention analyses and
experimental vaccine efficacy trials. In addition these studies
provide a springboard for future analyses of more severe
complications of viral influenza, including primary influenza
pneumonia and secondary bacterial pneumonia [23]. Future
studies will also be focused on identifying the etiologic agents for
the nearly 60% of ILI cases that remain undiagnosed. Retrospec-
tive analyses of these stored samples will be necessary to identify
other circulating ILI-related viruses, including coronaviruses,
HMPV and rhinoviruses, many of which can have severe disease
outcomes particularly in young children and the elderly. In
addition, bacterial pathogens are likely responsible for some of
those undiagnosed cases and will need to be considered. We didn’t
test for bacterial infections and may have a role in some ILI cases
either as primary or secondary infections.
Such further analyses are necessary to better understand the
pathogens in circulation and associated with ILI in the region, as
well as to define the relative disease burden imposed by each
pathogen.
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